Journal Article PreJuSER-60181

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2007
Academy Washington, DC

Proceedings of the National Academy of Sciences of the United States of America 104, 9810 - 9815 () [10.1073/pnas.0703137104]

This record in other databases:      

Please use a persistent id in citations: doi:

Abstract: We investigated the therapeutic effects of two different versions of Abeta(1-15 (16)) liposome-based vaccines. Inoculation of APP-V717IxPS-1 (APPxPS-1) double-transgenic mice with tetra-palmitoylated amyloid 1-15 peptide (palmAbeta(1-15)), or with amyloid 1-16 peptide (PEG-Abeta(1-16)) linked to a polyethyleneglycol spacer at each end, and embedded within a liposome membrane, elicited fast immune responses with identical binding epitopes. PalmAbeta(1-15) liposomal vaccine elicited an immune response that restored the memory defect of the mice, whereas that of PEG-Abeta(1-16) had no such effect. Immunoglobulins that were generated were predominantly of the IgG class with palmAbeta(1-15), whereas those elicited by PEG-Abeta(1-16) were primarily of the IgM class. The IgG subclasses of the antibodies generated by both vaccines were mostly IgG2b indicating noninflammatory Th2 isotype. CD and NMR revealed predominantly beta-sheet conformation of palmAbeta(1-15) and random coil of PEG-Abeta(1-16). We conclude that the association with liposomes induced a variation of the immunogenic structures and thereby different immunogenicities. This finding supports the hypothesis that Alzheimer's disease is a "conformational" disease, implying that antibodies against amyloid sequences in the beta-sheet conformation are preferred as potential therapeutic agents.

Keyword(s): Alzheimer Disease: prevention & control (MeSH) ; Alzheimer Vaccines: immunology (MeSH) ; Alzheimer Vaccines: pharmacology (MeSH) ; Amyloid beta-Peptides: immunology (MeSH) ; Amyloid beta-Peptides: metabolism (MeSH) ; Amyloid beta-Protein Precursor: genetics (MeSH) ; Analysis of Variance (MeSH) ; Animals (MeSH) ; Antigens: immunology (MeSH) ; Brain: immunology (MeSH) ; Brain: metabolism (MeSH) ; Cytokines: metabolism (MeSH) ; Enzyme-Linked Immunosorbent Assay (MeSH) ; Epitope Mapping (MeSH) ; Liposomes: immunology (MeSH) ; Mice (MeSH) ; Mice, Transgenic (MeSH) ; Nuclear Magnetic Resonance, Biomolecular (MeSH) ; Oligopeptides: genetics (MeSH) ; Peptide Fragments: immunology (MeSH) ; Recognition (Psychology): drug effects (MeSH) ; Alzheimer Vaccines ; Amyloid beta-Peptides ; Amyloid beta-Protein Precursor ; Antigens ; Cytokines ; Liposomes ; Oligopeptides ; PS1 antigen ; Peptide Fragments ; J ; Alzheimer's disease (auto) ; beta-amyloid (auto) ; vaccine (auto)


Note: Record converted from VDB: 12.11.2012

Contributing Institute(s):
  1. Molekulare Biophysik (INB-2)
Research Program(s):
  1. Funktion und Dysfunktion des Nervensystems (P33)

Appears in the scientific report 2007
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > IBI > IBI-7
Workflow collections > Public records
ICS > ICS-6
Publications database

 Record created 2012-11-13, last modified 2020-04-02


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)